16 studies on Nrf2 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research highlights GHK-Cu as a promising compound with significant anti-aging potential, acting through fundamental cellular mechanisms. The findings suggest that targeting mitochondrial health and activating co…
This research provides compelling evidence that combining Liraglutide with Atorvastatin offers a synergistic therapeutic strategy for managing metabolic dysfunction, inflammation, and oxidative stress. The identificat…
This research significantly advances our understanding of Humanin's neuroprotective capabilities and its potential as a therapeutic agent for neurodegenerative conditions characterized by oxidative stress, such as Par…
This research highlights NDP-MSH as a promising therapeutic candidate for treating intracerebral hemorrhage by targeting multiple pathways involved in secondary brain injury. By activating the Melanocortin-1 Receptor …
This research highlights AD-IR10 as a promising novel therapeutic agent for accelerating diabetic wound healing. Its unique mechanism of action, involving the reprogramming of macrophage metabolism via the Keap1/Nrf2/…
This study provides compelling evidence that HepatoGuard-1 has significant preventive effects against high-fat diet-induced NAFLD and associated metabolic dysfunction. The findings suggest that this novel food-derived…
This research provides compelling evidence for Elamipretide's therapeutic potential in treating Idiopathic Pulmonary Fibrosis by targeting a crucial inflammatory and fibrotic pathway. The ability of Elamipretide to mo…
This groundbreaking research highlights MOTS-c as a highly promising novel therapeutic agent for the prevention and treatment of radiation pneumonitis. Its ability to simultaneously modulate inflammation, reduce oxida…
This study provides compelling evidence that MOTS-c offers a robust protective effect against lung ischemia-reperfusion injury through a novel MYH9-dependent mechanism. The identification of MYH9 as a key mediator lin…
This study highlights MOTS-c as a promising therapeutic agent that can effectively combat diabetic liver fibrosis by mimicking the beneficial effects of exercise. Its ability to modulate key anti-fibrotic and antioxid…
This research highlights MOTS-c as a promising novel therapeutic agent for allergic asthma, offering a unique approach by targeting a fundamental aspect of the disease: airway barrier dysfunction and epithelial apopto…
This research highlights MOTS-c as a promising therapeutic candidate for osteoarthritis, offering a novel approach by simultaneously targeting mitochondrial health, reducing inflammatory cell death, and activating pro…
This research highlights MOTS-c as a highly promising therapeutic candidate for intrauterine growth restriction (IUGR), a condition currently plagued by limited effective treatment options. By demonstrating its abilit…
This research is highly significant as it identifies MOTS-c as a promising therapeutic candidate for preventing or treating bronchopulmonary dysplasia, a major cause of morbidity in premature infants. By activating th…
This research represents a pivotal advancement in peptide delivery technology, effectively overcoming the significant challenges of peptide instability and poor bioavailability under harsh conditions. The development …